HomeUS FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon TherapeuticsFILE PHOTO: An Amgen sign is seen at the company’s

FILE PHOTO: An Amgen sign is seen at the company’s

FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File Photo

Most Read

Teledyne’s fourth-quarter profit beats on robust defense demand

January 22, 2025

Microsoft’s LinkedIn sued for disclosing customer information to train AI models

January 22, 2025

Google adds SandboxAQ’s quantitative AI models to cloud offerings

January 22, 2025

Goldman Sachs CEO says important for US, China to improve ties, CNBC reports

January 22, 2025